Breaking News Instant updates and real-time market news.

SMMT

Summit Therapeutics

$1.20

-0.035 (-2.83%)

07:14
06/18/19
06/18
07:14
06/18/19
07:14

Summit Therapeutics announces increased BARDA award up to $63.7M

Summit Therapeutics announces that the Biomedical Advanced Research and Development Authority has increased the total value of its award for the clinical and regulatory development of Summit's precision antibiotic ridinilazole for the treatment of C. difficile infection to up to $63.7M. Under this award, BARDA has opted to exercise the next contract option for $9.6M, which will support patient enrollment and dosing in the ongoing Phase 3 clinical trials of ridinilazole. The total committed funding from the BARDA award under Contract No. HHS0100201700014C is now $53.6M, with one final option remaining. The final option provides funding support for potential applications for marketing approvals of ridinilazole. The BARDA contract provides for a cost-sharing arrangement with the committed funding drawn down over a specified development period.

SMMT Summit Therapeutics
$1.20

-0.035 (-2.83%)

06/28/18
JMPS
06/28/18
DOWNGRADE
JMPS
Market Perform
Summit Therapeutics downgraded to Market Perform at JMP Securities
06/28/18
JANY
06/28/18
DOWNGRADE
JANY
Neutral
Summit Therapeutics downgraded to Neutral from Buy at Janney Montgomery Scott
06/28/18
RHCO
06/28/18
DOWNGRADE
Target $4
RHCO
Hold
Summit Therapeutics downgraded to Hold at SunTrust on failed phase 2 DMD study
As reported earlier, SunTrust analyst Edward Nash downgraded Summit Therapeutics to Hold from Buy and lowered his price target to $4 from $22. The analyst cites the company's failed phase 2 study on Duchenne muscular dystrophy treatment as its stock price plunged nearly 80% intraday, adding that Summit will now discontinue ezutromid development and focus on the antibiotic program for C difficile infection. Nash further notes that the company's new lead product candidate, Ridinilazole, is now expected to enter phase 3 trials in Q1 of FY19.
06/29/18
HCWC
06/29/18
NO CHANGE
Target $3
HCWC
Buy
Summit Therapeutics price target lowered to $3 from $20 at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay lowered his price target for Summit Therapeutics to $3 after the company discontinued the development of ezutromid upon the full analysis of the 48-week data. Summit is now leveraged to its Phase 3 ready, differentiated, novel, gut flora sparing antibiotic for the treatment of Clostridium difficile, Chattopadhyay tells investors in a research note. Unfortunately, the Phase 3 program is not expected to commence until Q1 of 2019 and may not readout until 2021, the analyst adds. He believes, however, that the "damage to the stock is already done with the company trading at cash." Chattopadhyay sees "no value in moving to the sidelines" and keeps a Buy rating on Summit.

TODAY'S FREE FLY STORIES

GLPG

Galapagos

$169.98

24.31 (16.69%)

, GILD

Gilead

$68.00

1.75 (2.64%)

14:56
07/15/19
07/15
14:56
07/15/19
14:56
Downgrade
Galapagos, Gilead rating change  »

Galapagos downgraded to…

GLPG

Galapagos

$169.98

24.31 (16.69%)

GILD

Gilead

$68.00

1.75 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 26

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

JPM

JPMorgan

$114.02

-1.3 (-1.13%)

, JNJ

Johnson & Johnson

$134.89

0.6 (0.45%)

14:53
07/15/19
07/15
14:53
07/15/19
14:53
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JPM

JPMorgan

$114.02

-1.3 (-1.13%)

JNJ

Johnson & Johnson

$134.89

0.6 (0.45%)

WFC

Wells Fargo

$46.66

-0.69 (-1.46%)

GS

Goldman Sachs

$211.67

-2.28 (-1.07%)

PLD

Prologis

$80.11

0.08 (0.10%)

FRC

First Republic

$98.89

-1.74 (-1.73%)

DPZ

Domino's Pizza

$269.81

-12.42 (-4.40%)

SNV

Synovus

$34.65

-0.78 (-2.20%)

FHN

First Horizon

$14.89

-0.22 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 29

    Jul

  • 30

    Jul

  • 06

    Aug

  • 27

    Aug

  • 28

    Aug

  • 06

    Sep

  • 09

    Sep

  • 16

    Sep

  • 23

    Sep

  • 12

    Oct

  • 13

    Nov

JBHT

J.B. Hunt

$92.62

-0.33 (-0.36%)

14:52
07/15/19
07/15
14:52
07/15/19
14:52
Earnings
Notable companies reporting after market close »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 26

    Aug

  • 13

    Nov

JBHT

J.B. Hunt

$92.62

-0.33 (-0.36%)

14:49
07/15/19
07/15
14:49
07/15/19
14:49
Options
J B Hunt Transport Services options imply 7.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 26

    Aug

  • 13

    Nov

AGRX

Agile Therapeutics

$1.30

0.01 (0.78%)

14:48
07/15/19
07/15
14:48
07/15/19
14:48
Recommendations
Agile Therapeutics analyst commentary at Oppenheimer »

FDA guidance looks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$41.82

0.575 (1.39%)

14:45
07/15/19
07/15
14:45
07/15/19
14:45
Options
Taiwan Semi call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

ALTR

Altair

$41.54

0.37 (0.90%)

14:37
07/15/19
07/15
14:37
07/15/19
14:37
Hot Stocks
Altair beneficial owner George Christ sells $1.5M in company shares »

Altair beneficial owner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$211.82

-2.13 (-1.00%)

, BAC

Bank of America

$29.19

-0.25 (-0.85%)

14:36
07/15/19
07/15
14:36
07/15/19
14:36
Earnings
Fly Intel: What to watch in next round of big banks' earnings reports »

Goldman Sachs (GS), Bank…

GS

Goldman Sachs

$211.82

-2.13 (-1.00%)

BAC

Bank of America

$29.19

-0.25 (-0.85%)

MS

Morgan Stanley

$44.60

-0.27 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 06

    Aug

  • 06

    Sep

AMBA

Ambarella

$46.20

-0.06 (-0.13%)

14:35
07/15/19
07/15
14:35
07/15/19
14:35
Options
Ambarella put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$300.59

-0.09 (-0.03%)

, SPX

S&P 500

$0.00

(0.00%)

14:29
07/15/19
07/15
14:29
07/15/19
14:29
General news
Mnuchin said he thinks a budget deal is 'close' »

Treasury Secretary Steve…

SPY

SPDR S&P 500 ETF Trust

$300.59

-0.09 (-0.03%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$300.57

-0.11 (-0.04%)

, SPX

S&P 500

$0.00

(0.00%)

14:27
07/15/19
07/15
14:27
07/15/19
14:27
General news
Mnuchin says had 'very productive' talks with Pelosi on debt ceiling »

Treasury Secretary Steve…

SPY

SPDR S&P 500 ETF Trust

$300.57

-0.11 (-0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGC

LogicBio Therapeutics

$12.55

0.41 (3.38%)

14:26
07/15/19
07/15
14:26
07/15/19
14:26
Conference/Events
LogicBio Therapeutics management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

QURE

uniQure

$68.66

-1.74 (-2.47%)

14:25
07/15/19
07/15
14:25
07/15/19
14:25
Options
uniQure call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

AVGO

Broadcom

$290.65

5.26 (1.84%)

, SYMC

Symantec

$21.78

-3.78 (-14.79%)

14:21
07/15/19
07/15
14:21
07/15/19
14:21
Periodicals
Broadcom still keen to find solution as Symantec bid stalls over price, FT says »

Broadcom's (AVGO)…

AVGO

Broadcom

$290.65

5.26 (1.84%)

SYMC

Symantec

$21.78

-3.78 (-14.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
07/15/19
07/15
14:17
07/15/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
07/15/19
07/15
14:16
07/15/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$26.49

-0.32 (-1.19%)

14:15
07/15/19
07/15
14:15
07/15/19
14:15
Options
KKR put volume heavy and directionally bearish »

Bearish flow noted in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

14:15
07/15/19
07/15
14:15
07/15/19
14:15
General news
Fed funds futures are fractionally higher »

Fed funds futures are…

FB

Facebook

$203.96

-0.945 (-0.46%)

, BTC

Bitcoin

$0.00

(0.00%)

14:14
07/15/19
07/15
14:14
07/15/19
14:14
Hot Stocks
Mnuchin says Trump has cryptocurrency concerns, won't target a specific provider »

Asked about President…

FB

Facebook

$203.96

-0.945 (-0.46%)

BTC

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 24

    Jul

C

Citi

$71.87

0.12 (0.17%)

14:11
07/15/19
07/15
14:11
07/15/19
14:11
Hot Stocks
Citi reports June credit loss rate 2.56% vs. 2.74% last month »

Reports June 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 13

    Aug

FB

Facebook

$203.77

-1.135 (-0.55%)

14:09
07/15/19
07/15
14:09
07/15/19
14:09
Hot Stocks
Breaking Hot Stocks news story on Facebook »

Mnuchin says Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 24

    Jul

FB

Facebook

$203.81

-1.095 (-0.53%)

, BTC

Bitcoin

$0.00

(0.00%)

14:07
07/15/19
07/15
14:07
07/15/19
14:07
Hot Stocks
Mnuchin says Treasury has 'serious concerns' about Facebook's Libra, bitcoin »

Treasury Secretary Steven…

FB

Facebook

$203.81

-1.095 (-0.53%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 24

    Jul

SCHW

Charles Schwab

$40.49

0.47 (1.17%)

14:05
07/15/19
07/15
14:05
07/15/19
14:05
Options
Charles Schwab call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

CSGP

CoStar Group

$583.45

-3.56 (-0.61%)

14:05
07/15/19
07/15
14:05
07/15/19
14:05
Hot Stocks
CoStar Group signs agreement with Behar Group Realty »

CoStar Group is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 12

    Aug

  • 13

    Nov

HTGC

Hercules Capital

$12.96

-0.02 (-0.15%)

14:00
07/15/19
07/15
14:00
07/15/19
14:00
Hot Stocks
Hercules Capital reports separation agreement with Manuel Henriquez »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.